Todd Asset Management’s Royalty Pharma RPRX Stock Holding History

Todd Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$35M	Buy	+600,448	New	+$35.4M	0.64%	72

Other funds holding RPRX

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Marathon Asset Management (UK) London, United Kingdom $2.2B AUM 25.78% 1-Year Est. Return

Todd Asset Management's RPRX Position: Q3 2026 in Review

Todd Asset Management opened a new position in Royalty Pharma (RPRX) in Q3 2026: 600,448 shares worth $35M. The stake represents 0.64% of the portfolio and ranks #72 among its holdings.

165 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

Todd Asset Management held 600,448 shares of Royalty Pharma worth $35M as of Q3 2026.
Royalty Pharma was a new Todd Asset Management position in Q3 2026.
Royalty Pharma made up 0.64% of Todd Asset Management's portfolio in Q3 2026, its #72 holding.
165 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Todd Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.